These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3132191)

  • 1. Biochemical assessment of acute and chronic treatment of Paget's bone disease with calcitonin and calcium with and without biphosphonate.
    Rico H; Hernández ER; Younes M; Hernández D; Espinós D
    Bone; 1988; 9(1):63-6. PubMed ID: 3132191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR; Ibbertson HK; Holdaway IM; Rutland M; King A; Dodd G; Wattie DJ
    Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study].
    Eisinger J; Laponche AM; Ouaniche J
    Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183-5. PubMed ID: 3085204
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
    O'Donoghue DJ; Hosking DJ
    Bone; 1987; 8(4):219-25. PubMed ID: 3128315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
    Jaeger P; Bischoff-Delaloye A; Burckhardt P
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M; Khairi A; Johnston C
    Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Paget's disease of bone.
    Evans RA
    Med J Aust; 1983 Feb; 1(4):159-62. PubMed ID: 6405139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
    Miravet L; Kuntz D
    Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):287-92. PubMed ID: 2496460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcitonin or EHDP in Paget's disease?
    Bijvoet OL; Hosking DJ; Van Aken J; Will EJ
    Calcif Tissue Res; 1977 May; 22 Suppl():494. PubMed ID: 410489
    [No Abstract]   [Full Text] [Related]  

  • 11. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy.
    Siris ES; Canfield RE; Jacobs TP; Stoddart KE; Spector PJ
    Metab Bone Dis Relat Res; 1981; 3(4-5):301-8. PubMed ID: 6820111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.
    Evans RA; Somers NM; Dunstan CR; Hills E; Evans M
    Calcif Tissue Int; 1991 Sep; 49(3):164-7. PubMed ID: 1933580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
    Sieghart S
    Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of the therapeutic sequence calcitonin-EHDP in Paget's disease].
    Eisinger J; Schiano A; d'Omezon Y; Ouaniche J
    Rev Rhum Mal Osteoartic; 1983 Mar; 50(3):245-6. PubMed ID: 6408727
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcitonin and diphosphonate in the treatment of Paget's disease of bone.
    Hosking DJ
    Metab Bone Dis Relat Res; 1981; 3(4-5):317-26. PubMed ID: 6820113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of Paget's disease of bone].
    Mimura K
    Nihon Seikeigeka Gakkai Zasshi; 1985 Aug; 59(8):751-61. PubMed ID: 3936894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procollagen-III peptide serum levels in Paget's disease of the bone.
    Wilder-Smith CH; Raue F; Holz-Gottswinter G; Ziegler R
    Klin Wochenschr; 1987 Feb; 65(4):174-8. PubMed ID: 3104661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.